Micro-x Ltd. · ASX:MX1
Micro-x — ASX Small and Mid-Cap Conference 2021
17 slides from Micro-x's conference presentation, Mar 15, 2021
Slide 1: ASX announcement: Micro-X to appear at ASX Small and Mid-Cap Conference
Micro-X Limited, ABN 21 153 273 735 ASX SMALL AND MID-CAP CONFERENCE 16 - 17 March 2021, Virtual Conference For personal use only Adelaide, Australia, 15 March 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technology for the healthcar
Slide 2: ASX Small and Mid-Cap Conference: A new era in X-ray imaging
For personal use only ACN 153 273 735 ASX: MX1 ASX Small and Mid-Cap Conference 16 - 17 March 2021 Peter Rowland Managing Director & CEO A new era in X-ray imaging
Slide 3: Important Notice and Disclaimer
I M P O R TA N T N O T I C E DISCLAIMER SCOPE & LIMITATIONS This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not For personal use only contain all the information about the Company’s assets and liabilities, financi
Slide 4: Overview: Next generation X-ray for global health and security markets
OVERVIEW NEXT GENERATION X-RAY FOR GLOBAL HEALTH AND SECURITY MARKETS For personal use only Platform technology in cold cathode x-ray • X-ray products with significant reduction in size, weight and power • Patented technology – platform for health and new security applications • First to market with
Slide 5: Our Strategy: Monetise our first mover advantage
O U R S T R AT E G Y MONETISE OUR ‘FIRST MOVER’ ADVANTAGE For personal use only OUR GOAL Successful first movers in breakthrough technology move Four global production lines: Commercialise high in the quickly: - common technology platforms value chain to maximise early commercial domination revenue
Slide 6: Four production lines: sequenced product rollout as CNT manufacturing expands
O IVGENRI VF I E S CWA NOT FMMAIRCKREOT- S X ACROSS FOUR PRODUCTION LINES Next generation X-ray for global health and security markets SEQUENCED PRODUCT ROLLOUT AS CNT MANUFACTURING EXPANDS For personal use only MOBILE BEDSIDE DR IED X-RAY CAMERA AIRPORT CHECKPOINT BRAIN CT SCANNER 2018 2022* 2023*
Slide 7: Mobile DR: Nano mobile x-ray for healthcare
M O B I L E D R : N A N O M O B I L E X - R AY F O R H E A L T H C A R E APPROVED FOR SALE IN 40 COUNTRIES – significant COVID-19 sales demand For personal use only $4.2m Bedside imaging – hospitals & temporary facilities Small & portable – 95kg compared to 350-600kg Purchase orders in Approvals – F
Slide 8: Mobile DR: Rover for military and remote users
M O B I L E D R : R O V E R F O R M I L I TA RY & R E M O T E U S E R S FIRST CONTRACT FOR ADF - STRONG MILITARY INTEREST & UNMET NEED For personal use only $1.4m Rover is an adapted version of the Nano for military use • Deployed medical facilities treat injured military personnel • Higher power fo
Slide 9: IED Imaging Camera
IED IMAGING CAMERA BACKSCATTER X-RAY ASSESSMENT OF IEDS VIA ROBOT For personal use only $1.8b X-Ray camera takes images without separate detector– one sided viewing Addressable market Bomb disposal technicians face life threatening situation when placing conventional X-ray detector behind target Aus
Slide 10: Airport Self-Service Checkpoint
AIRPORT SELF-SERVICE CHECKPOINT US DEPT OF HOMELAND SECURITY - TWO CONTRACTS TOTALLING US$4M For personal use only • A blend of backscatter and transmission X-ray to provide three dimensional imaging of carry on luggage US$24.0b • Integrated body scanner and passport reader Addressable market • Base
Slide 11: Brain Tomography for Stroke Diagnosis
BRAIN TOMOGRAPHY FOR STROKE DIAGNOSIS MOBILE POINT-OF-CARE DIAGNOSIS - $8M MRFF FUNDING AWARDED For personal use only US$5.0b Addressable market • New medical imaging technology for enhanced diagnosis of strokes in a mobile setting - road or air ambulance • Curved detector will be the first of its k
Slide 12: Established Capabilities
E S TA B L I S H E D C A PA B I L I T I E S KEY DISCIPLINES – MANUFACTURING, ENGINEERING DESIGN & IMAGE PROCESSING For personal use only • State of the art manufacturing facility spanning over 2,000m2 • ISO 13485 certified Quality Management System 2 Mobile DR Production capacity a day • ~ 95% Austr
Slide 13: Experienced Leadership
EXPERIENCED LEADERSHIP TECHNICAL AND COMMERCIAL EXPERTISE TO SUPPORT OUR OBJECTIVES For personal use only Peter Rowland David Knox Patrick O’Brien Yasmin King Dr Alexander Gosling, AM Jim McDowell Managing Director & CEO Non-Executive Chairman Non-Executive Director Non-Executive Director Non-Execut
Slide 14: Corporate Snapshot
C O R P O R AT E S N A P S H O T GROWTH STAGE COMPANY WITH INSTITUTIONAL SUPPORT For personal use only MX1 - Share Trading ( 1 January 2020 to 3 March 2021) Millions $0.45 25.0 $0.40 $0.35 20.0 $0.30 15.0 $0.25 $0.20 10.0 $0.15 $0.10 5.0 $0.05 $0.00 0.0 02 09 16 23 30 06 13 20 27 05 12 19 26 02 09 1
Slide 15: Expected Milestones & News Flow
OVERVIEW OF MICRO-X EXPECTED MILESTONES & NEWS FLOW Next generation X-ray for global health and security markets INITIATIVES TO DELIVER COMMERCIAL OUTCOMES FOR ALL STAKEHOLDERS For personal use only First IED Camera Demonstration Ongoing Nano and Rover Sales Grow Nano and Rover paths to market Brain
Slide 16: Conclusion: Unlocking value from revolutionary cold cathode technology
CONCLUSION UNLOCKING VALUE FROM REVOLUTIONARY COLD CATHODE TECHNOLOGY For personal use only • Own the proven technical edge • Products with revenues in 26 counties • Multiple product lines in design • Massive addressable markets • Customer pull – not technology push • Demonstrated design & manufactu
Slide 17: Thank You
For personal use only ACN 153 273 735 ASX: MX1 Thank You Peter Rowland Managing Director & CEO A new era in X-ray imaging